Emily Whitehead, First Pediatric Patient to Receive CAR T-Cell Therapy, Celebrates Cure 10 Years Later
Whitehead received life-saving treatment at CHOP, under the care of Dr. Stephan Grupp, transforming the field of cancer immunotherapy.
Read moreNews Room
11 - 20 of 2095
CHOP Researchers Find Rate of Fatal Opioid Poisonings Among Children More Than Doubled Over 13-Year Span
Published on in CHOP News
Over-the-counter drugs also continue to pose fatal risks to young children despite measures to reduce exposure.
Children’s Hospital of Philadelphia Establishes the Martha Escoll Lubeck Feeding and Swallowing Center
Published on in CHOP News
$4 million gift from the Escoll-Lubeck Charitable Foundation will support innovative and high-quality care to children with feeding and swallowing disorders and their families.
How Vision Can Support or Delay Learning in a Child with Down Syndrome: Part 3
Published on in Trisomy 21 Update
Once an individual collects visual input from their environment, they must organize, interpret, evaluate this information to make decisions about how to interact with their environment.
CHOP Partners With Ethiopian Family to Spread Down Syndrome Awareness
Published on in Trisomy 21 Update
CHOP’s Trisomy 21 team partners with patient family and the Deborah Foundation to spread awareness and education about Down syndrome to Ethiopia.
Toilet Training Children and Adolescents with Down Syndrome
Published on in Trisomy 21 Update
Toilet training for children and adolescents with Down syndrome may take longer to learn because of a variety of tasks that need to be mastered and coordinated to successfully void on the toilet.
CHOP Selected As New Center for Turning Research Results Into Clinical Practice
Published on in CHOP News
CHOP is one of 42 institutions selected by the Patient-Centered Outcomes Research Institute (PCORI) as part of the $50 million initiative.
Meet the HI Center’s Nurse Coordinators
Published on in HI Hope
Nurse coordinators at the Congenital Hyperinsulinism Center assist patient families before the first appointment and through admission and follow-up.
Meet Sophie Foss, PhD, HI Center Neuropsychologist
Published on in HI Hope
Sophie Foss, PhD, has joined the CHOP Congenital Hyperinsulinism Center as its neuropsychologist. See how she can help your child.
The Difference Between Dominant and Recessive Gene Mutations
Published on in HI Hope
Congenital hyperinsulinism (HI) is often passed from parent to child through a gene variant. Here’s how dominant and recessive gene variants work.
FDA Approves First Drug for Friedreich’s Ataxia
Published on in CHOP News
The drug, omaveloxolone, is a once-a-day pill that will help improve neurological function and slow progression of the neurodegenerative disease.